Research Articles
Pharmacokinetics of Morphine and its Surrogates VII: High-Performance Liquid Chromatographic Analyses and Pharmacokinetics of Methadone and its Derived Metabolites in Dogs

https://doi.org/10.1002/jps.2600741114Get rights and content

Abstract

Reversed-phase HPLC assays with on-column UV detection and post-column fluorescent detection of ion pair-extracted material were developed and used for the quantitative assay of methadone, its presumed metabolites, and acid- and alkali-hydrolyzable conjugates of these metabolites in biological fluids with assay sensitivities of 10–20 ng/mL. Plasma, urine, and bile were monitored in dogs after intravenous bolus administration of 0.8, 10, 20, and 2.2 mg/kg methadone hydrochloride. Plasma—time data showed two sequential half-lives of 8.3 ± 3.4 (SEM) and 128 ± 37 min, with apparent dose-independent pharmacokinetics in the studied dose range. Total body clearances were 899 ± 103 (SEM) mL/min. Renal clearances (6–82 mL/min) of methadone were highly variable within and among studies but showed no significant variation with urinary pH or flow rate. The percentages of the dose excreted in the urine as methadone and (+)-2-ethyl-1,5-dimethyl-3,3-diphenylpyrroline (2) were 3.6 ± 0.5% (SEM) and 4.1 ± 0.4% (SEM), respectively, but there were no significant concentrations of 2 in plasma. The presumed metabolites 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (3), 1,5-dimethyl-3,3-diphenyl-2-pyrrolidone (4), (—)-α-N-normethadol (7), 4-dimethylamino-2,2-diphenylvaleric acid (8), p-hydroxymethadone (9), and (—)-α-methadol (10) were not observed in the plasma of dogs given methadone. Quantities of presumed metabolites 3, 4, 7, 8, 9, and 10 were negligible in urine (< 0.03% of dose). No acid-hydrolyzable conjugates, or generators on acidification, of 3, 4, 7, 8, or 10 were detectable in urine. No alkali-hydrolyzable conjugates, or generators on alkalinization, of 3, 4, 8, or 10 were detectable in urine. There was no significant bilary secretion of unchanged methadone; 2 in bile amounted to only 2% of the dose. In bile and urine, 50% and 17–27%, respectively, of the radiolabeled dose was not extractable into hexane. In a non-bile-cannulated dog, 35% of the total radiolabeled intravenous dose was present in the feces. As much as 88% of an intravenous radiolabeled dose could be accounted for, even though only small amount of methadone was disposed through the metabolic routes claimed in the literature. The intravenous administration of 2 resulted in two sequential half-lives of 3 and 270 min and no apparent pharmacokinetic dose dependency. Amounts of 2 excreted unchanged in urine and bile were 23% and 5–16% of the dose, respectively. Renal and total body clearances were 170 and 1150 mL/min. Only 16–22% of intravenously administered, systemically available methadone is transformed to 2 in dogs.

References and Notes (29)

  • S.D. Ferrara et al.

    Forensic Sci.

    (1978)
  • H. Derendorf et al.

    J. Pharm. Sci.

    (1983)
  • E.R. Garrett et al.

    J. Pharm. Sci.

    (1983)
  • G.S.F. Ling et al.

    J. Pharmacol. Exp. Ther.

    (1981)
  • A.L. Misra et al.

    J. Pharmacol. Exp. Ther.

    (1973)
  • A.L. Misra et al.

    J. Pharmacol. Exp. Ther.

    (1974)
  • A.L. Misra et al.

    Xenobiotica

    (1975)
  • C.E. Inturrisi et al.

    Clin. Pharmacol. Ther.

    (1972)
  • K. Verebely et al.

    Clin. Pharmacol. Ther.

    (1975)
  • M.-I. Nilsson et al.

    Eur. J. Clin. Pharmacol.

    (1982)
  • E. Anggard et al.

    Eur. J. Clin. Pharmacol.

    (1979)
  • V. Meresaar et al.

    Eur. J. Clin. Pharmacol.

    (1981)
  • M.-I. Nilsson et al.

    Eur. J. Clin. Pharmacol.

    (1982)
  • M.-I. Nilsson et al.

    Acta Anaesthesiol. Scand. Suppl.

    (1982)
  • Cited by (29)

    • The effect of fluconazole on oral methadone in dogs

      2019, Veterinary Anaesthesia and Analgesia
      Citation Excerpt :

      The formation of the active tramadol metabolite (O-desmethyltramadol) was increased due to a different CYP responsible for that metabolic pathway. The metabolites of methadone are inactive and have not been well described in dogs (Garrett et al. 1985). Therefore, we did not quantify changes in methadone metabolic pathways or metabolite formation.

    • Evaluation of methadone concentrations in bitches and in umbilical cords after epidural or systemic administration for caesarean section: A randomized trial

      2019, Veterinary Anaesthesia and Analgesia
      Citation Excerpt :

      In the present study, the methadone concentrations in the plasma of the bitches and in the umbilical cords of their puppies were evaluated after epidural or systemic administration for analgesia during emergency caesarean section. There is a paucity of information concerning the pharmacokinetics of methadone in dogs after epidural administration (Garrett et al. 1985; Schmidt et al. 1994; Ingvast-Larsson et al. 2010). In human medicine, epidurally administered methadone reached peak plasma concentrations within 10–20 minutes, similar to those observed after IM injection, in the same patients (Max et al. 1985).

    • Chloramphenicol significantly affects the pharmacokinetics of oral methadone in Greyhound dogs

      2015, Veterinary Anaesthesia and Analgesia
      Citation Excerpt :

      Significant effects on the MRT and terminal half-life occurred in the chloramphenicol treatments, suggesting that inhibited elimination was a substantial component of this drug interaction. Biliary and renal secretion of intact methadone is low in dogs, which suggests that transporters such as P-gp are not prominent pathways of methadone elimination in dogs (Garrett et al. 1985). Further studies assessing the in vitro metabolism of methadone, the effects of P-gp on methadone transport in dogs and the effects of chloramphenicol on transporters in dogs are needed to fully elucidate the drug–drug interaction between methadone and chloramphenicol in dogs.

    • The effects of concurrent administration of cytochrome P-450 inhibitors on the pharmacokinetics of oral methadone in healthy dogs

      2011, Veterinary Anaesthesia and Analgesia
      Citation Excerpt :

      Previous studies have described the pharmacokinetics of intravenous (IV) methadone in dogs (Garrett et al. 1985; Schmidt et al. 1994; KuKanich et al. 2005a; KuKanich & Borum 2008). Methadone has a short half-life of approximately 2–4 hours and a rapid clearance approximating hepatic blood flow, suggesting that it has a high hepatic extraction ratio (Garrett et al. 1985; Schmidt et al. 1994; KuKanich et al. 2005a; KuKanich & Borum 2008). Drugs with a high hepatic extraction ratio (ER) often have a low oral bioavailability (F) due to first pass metabolism and can be estimated by the following equation: F = 1−ER (Riviere 1999).

    View all citing articles on Scopus
    View full text